arcoris bio
1 known investors
Arcoris bio develops MUSE®, a self-assembling, enzyme-free DNA nanotechnology for signal amplification and multiplex imaging that detects protein, DNA, and RNA biomarkers across assays such as immunofluorescence, immunohistochemistry, and in situ hybridization. It sells ready-to-use immunoMUSE® kits for researchers and offers custom solutions, licensing, and white-label/B2B technology integration to partners.
Investors · 1
Frequently asked questions
- What does arcoris bio do?
- Arcoris bio develops MUSE®, a self-assembling, enzyme-free DNA nanotechnology for signal amplification and multiplex imaging that detects protein, DNA, and RNA biomarkers across assays such as immunofluorescence, immunohistochemistry, and in situ hybridization. It sells ready-to-use immunoMUSE® kits for researchers and offers custom solutions, licensing, and white-label/B2B technology integration to partners.
- Who are arcoris bio's investors?
- arcoris bio's investors include Ventura BioMed Investors.